Atylosia goensis Dalz.
1. Taxonomic, Nomenclature & Therapeutic Summary Table
| Botanical Attribute | Pharmacognostic & Therapeutic Specification |
|---|---|
| Synonym | A. barbata Baker |
| Family | Papilionaceae; Fabaceae. |
| Habitat | Subtropical tract of Assam, Maharashtra and Kerala, up to 1050 m. |
| Ayurvedic | Maashaparni (substitute). |
| Siddha / Tamil | Peruvidukol. |
| Action | Febrifuge, antibilious, antirheumatic (used in consumption and swellings). |
| Taxonomic Cohort | Genus Atylosia (2 documented species); Family Papilionaceae (67 documented species). |
2. Classical Nomenclature, Taxonomy & Biogeographical Context
Atylosia goensis (taxonomically cited with authority Dalz.) is an established medicinal plant species in Indian materia medica. It is classified under the botanical family Papilionaceae; Fabaceae (primary family classification: Papilionaceae), placing it within a well-defined chemotaxonomic group of medicinal flora. In classical and modern botanical literature, the species is cross-referenced under the botanical synonymy A. barbata Baker, which is synchronized to prevent taxonomic ambiguity across regional herbal formularies. Biogeographically, its documented habitat and ecological distribution span: Subtropical tract of Assam, Maharashtra and Kerala, up to 1050 m.
Across classical and vernacular Indian systems of medicine, Atylosia goensis is recognized under distinct polyglot nomenclature: in the Ayurvedic system (synchronized across The Ayurvedic Pharmacopoeia of India, CCRAS Standard Nomenclature, Sharangadhara Samhita, and Bhava Prakash) as Maashaparni (substitute); in the Siddha and Tamil medical tradition (compiled from the Formulary of Siddha Medicine and IMPCOPS Chennai) as Peruvidukol. Romanized Sanskrit and Ayurvedic spellings follow standard National Academy of Ayurveda (Rashtriya Ayurveda Vidyapeeth) transliteration conventions, using double vowels to preserve authentic classical pronunciation across regional medical traditions.
3. Therapeutic Actions, Phytochemistry & Pharmacological Profile
In therapeutic and clinical pharmacognosy, the primary recorded actions and clinical indications of Atylosia goensis are: Febrifuge, antibilious, antirheumatic (used in consumption and swellings). These traditional and clinical attributes reflect the plant part-specific pharmacological profile documented across classical Indian treatises and modern herbal pharmacopoeias.
The therapeutic activity of Atylosia goensis is grounded in its documented pharmacological actions (Febrifuge, antibilious, antirheumatic (used in consumption and swellings)) and the characteristic secondary metabolite profile of the family Papilionaceae.

Botanical Reference 1: Atylosia goensis — Wikimedia Commons
4. Comparative Genus & Family Pharmacognosy
Taxonomically, the genus Atylosia comprises 2 distinct medicinal species in Indian herbal literature. Closely allied congeneric species include: Atylosia scarabaeoides (Action: Antidysenteric, anticholerin, febrifuge; also used in anaemia, anasarca and…). Comparing Atylosia goensis alongside its congeners in genus Atylosia highlights both shared secondary metabolite classes and species-specific organotropism across different ecological zones.
At the family level, Papilionaceae encompasses 67 documented medicinal species (3.69% of the 1,814-species flora). Other representative medicinal members of Papilionaceae include: Abrus precatorius Linn. (Gunjaa), Alhagi pseudalhagi (Yavaasaka), Arachis hypogaea (Mandapi), Atylosia scarabaeoides (Vana-kulattha), Butea monosperma (Paalasha). In comparative pharmacognosy, evaluating species within the same botanical family aids quality control, authentication of crude drugs, and identification of chemotaxonomic markers.

Figure 1: Quantitative documentation profile across all 67 medicinal species of family Papilionaceae.
5. Pharmacopoeial Standards, Posology & Reference Framework
In clinical and traditional dispensing, preparation and administration of Atylosia goensis follow the plant-part modalities specified under its therapeutic action (Febrifuge, antibilious, antirheumatic (used in consumption and swellings)), guided by the standard posological principles of The Ayurvedic Pharmacopoeia of India (Vols. I–IV) and CCRAS formularies. Classical and modern pharmacognostic synchronization for Atylosia goensis integrates standards from The Ayurvedic Pharmacopoeia of India, The National Formulary of Unani Medicine, Formulary of Siddha Medicine, The Wealth of India (CSIR), Compendium of Indian Medicinal Plants (CDRI), Dictionary of Indian Medicinal Plants (CIMAP), German Commission E, ESCOP, WHO monographs, British Herbal Pharmacopoeia, and Natural Medicines Comprehensive Database.